Profile
J.
Mark Hattendorf has been a Director of CryoCor, Inc. since July 2006.
From April 2005 to October 2006, he was Chief Financial Officer of EWI Holdings and worked at Peat Marwick Mitchell & Co. Mr. Hattendorf is a Certified Public Accountant and received an undergraduate degree in Accounting and an MBA in Finance from Loyola Marymount University.
Former positions of J. Mark Hattendorf
Companies | Position | End |
---|---|---|
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Director/Board Member | 28/05/2008 |
EWI Holdings, Inc.
EWI Holdings, Inc. Data Processing ServicesTechnology Services EWI Holdings, Inc. provides payment processing services. The company was founded by Miles Paschini in 1999 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Training of J. Mark Hattendorf
Loyola Marymount University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
EWI Holdings, Inc.
EWI Holdings, Inc. Data Processing ServicesTechnology Services EWI Holdings, Inc. provides payment processing services. The company was founded by Miles Paschini in 1999 and is headquartered in San Diego, CA. | Technology Services |
CryoCor, Inc.
CryoCor, Inc. Medical SpecialtiesHealth Technology CryoCor, Inc. provided medical technology services. It developed and manufactured a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The firm's product the CryoCor Cardiac Cryoablation System, was designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The company was founded in 2000 and was headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- J. Mark Hattendorf